GATA3-driven Th2 responses inhibit TGF-β1–induced FOXP3 expression and the formation of regulatory T cells
2007

GATA3 Inhibits FOXP3 and Inducible Tregs

publication 10 minutes Evidence: high

Author Information

Author(s): Mantel Pierre-Yves, Kuipers Harmjan, Boyman Onur, Rhyner Claudio, Ouaked Nadia, Rückert Beate, Karagiannidis Christian, Lambrecht Bart N, Hendriks Rudolf W, Crameri Reto, Akdis Cezmi A, Blaser Kurt, Schmidt-Weber Carsten B

Primary Institution: Swiss Institute of Allergy and Asthma Research Davos (SIAF), Davos-Platz, Switzerland

Hypothesis

Therapeutic agents aimed at neutralizing IL-4 could be a novel strategy to facilitate inducible Treg cell generation and thus promotion of tolerance in allergies and other Th2-dominated diseases.

Conclusion

GATA3 inhibits FOXP3 expression, preventing the generation of inducible Tregs, which may have implications for tolerance in allergic diseases.

Supporting Evidence

  • GATA3 directly binds to the FOXP3 promoter, inhibiting its expression.
  • IL-4 treatment in mice reduces iTreg cell frequency.
  • Th2 cells have a limited capacity to express FOXP3.

Takeaway

This study shows that a protein called GATA3 stops another protein, FOXP3, from doing its job, which is important for keeping our immune system in check, especially in allergies.

Methodology

The study involved analyzing the effects of IL-4 and GATA3 on FOXP3 expression in various T cell subsets through in vitro experiments and mouse models.

Limitations

The study primarily focuses on the in vitro and in vivo effects of GATA3 and IL-4, which may not fully represent the complexity of human immune responses.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pbio.0050329

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication